Healthcare stocks jump on US filings and big funding: Osteopore, Echo IQ and Anteris lead

• Osteopore jumped on a Hong Kong distribution deal that gives it a sales doorway into the Greater Bay Area.
• Echo IQ rose after filing for US FDA clearance, following Mayo Clinic validation results.
• Anteris surged as it locked in a large capital raise with Medtronic buying stock alongside public investors.
• Several “real revenue” updates didn’t stop sell-offs, showing investors still want near-term proof of sales.